Physician profile

Tracy D Gregory

Family · Dickson, TN

NPI 1285977322

$4,633.04

in general payments reported to CMS, 2019-2025

39 companies · $1,325 in 2025

The $1,325 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).

See the full distribution for Family

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,307.77
Education$99.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $928.10 2021-2025 Ozempic, Rybelsus, Wegovy
Astrazeneca Pharmaceuticals LP $455.66 2021-2025 Farxiga, Airsupra, Breztri
Lilly USA, LLC $360.76 2021-2025 Mounjaro, Zepbound, Jardiance
Abbvie INC. $294.54 2021-2025
Exact Sciences Corporation $271.42 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Amgen INC. $223.09 2023-2025 Evenity, Prolia, Otezla
Otsuka America Pharmaceutical, INC. $217.44 2022-2025 Rexulti, Abilify Maintena
Bayer Healthcare Pharmaceuticals INC. $212.33 2025
Janssen Pharmaceuticals, INC $188.34 2021-2025 Spravato
Pfizer INC. $136.37 2023-2025
Nestle Healthcare Nutrition INC. $123.45 2021
Astellas Pharma US INC $120.22 2024 Veozah
Sumitomo Pharma America, INC. $105.64 2024-2025 Gemtesa
Glaxosmithkline, LLC. $100.18 2022-2025 Trelegy Ellipta
Novartis Pharmaceuticals Corporation $94.83 2022-2023
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Esperion Therapeutics, INC. $84.08 2021
Takeda Pharmaceuticals U.S.A., INC. $74.02 2021-2025 Trintellix
Corcept Therapeutics $60.83 2021-2025 Korlym
Neurocrine Biosciences, INC. $56.18 2023 Ingrezza
Boehringer Ingelheim Pharmaceuticals, INC. $53.62 2021-2025 Jardiance
Amarin Pharma, INC. $52.91 2021
Dexcom, INC. $46.93 2022-2025 Dexcom G6 Transmitter
Nevro Corp. $45.20 2023-2024 Senza
Biohaven Pharmaceutical Holding Company LTD. $44.36 2022
Shield Therapeutics INC $32.53 2023 Accrufer
Merck Sharp & Dohme LLC $30.17 2021-2024 Dificid
Janssen Biotech, INC. $25.67 2024 Talvey, Tecvayli, Darzalex
Alkermes, INC. $22.79 2025 Vivitrol
Daiichi Sankyo INC. $20.69 2021
Antares Pharma, INC. $20.33 2022
Vbi Vaccine (Delaware) INC. $20.11 2022
Phathom Pharmaceuticals, INC. $18.00 2025 Voquezna
Corium, LLC $16.74 2023 Azstarys
Idorsia Pharmaceuticals US INC $15.67 2023 Quviviq
Medtronic, INC. $15.19 2024 Minimed 780g
Amneal Pharmaceuticals LLC $14.60 2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $13.94 2021
Almatica Pharma LLC $11.72 2021
Genentech USA, INC. $4.39 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tracy D Gregory

$4,633.04

in general payments reported 2019-2025

Years
2021-2025
Top company
Novo Nordisk INC
Context
The $1,325 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/10863807/tracy-d-gregory

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.